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AMPK directly inhibits NDPK through a 
phosphoserine switch to maintain cellular 
homeostasis
Rob U. Onyenwokea, Lawrence J. Forsberga, Lucy Liua, Tyisha Williamsa, Oscar Alzateb, 
and Jay E. Brenmana,b
aNeuroscience Center and bDepartment of Cell and Developmental Biology, University of North Carolina School of 
Medicine, Chapel Hill, NC 27599
ABSTRACT AMP-activated protein kinase (AMPK) is a key energy sensor that regulates me-
tabolism to maintain cellular energy balance. AMPK activation has also been proposed to 
mimic benefits of caloric restriction and exercise. Therefore, identifying downstream AMPK 
targets could elucidate new mechanisms for maintaining cellular energy homeostasis. We 
identified the phosphotransferase nucleoside diphosphate kinase (NDPK), which maintains 
pools of nucleotides, as a direct AMPK target through the use of two-dimensional differential 
in-gel electrophoresis. Furthermore, we mapped the AMPK/NDPK phosphorylation site (ser-
ine 120) as a functionally potent enzymatic “off switch” both in vivo and in vitro. Because ATP 
is usually the most abundant cellular nucleotide, NDPK would normally consume ATP, where-
as AMPK would inhibit NDPK to conserve energy. It is intriguing that serine 120 is mutated 
in advanced neuroblastoma, which suggests a mechanism by which NDPK in neuroblastoma 
can no longer be inhibited by AMPK-mediated phosphorylation. This novel placement of 
AMPK upstream and directly regulating NDPK activity has widespread implications for cel-
lular energy/nucleotide balance, and we demonstrate in vivo that increased NDPK activity 
leads to susceptibility to energy deprivation–induced death.
INTRODUCTION
AMP-activated protein kinase (AMPK) functions as a cellular en-
ergy sensor activated by hypoxia, low glucose, and other stressors 
that lower ATP levels and raise AMP levels (Hardie et al., 2006; 
Shaw, 2006). In response to AMP/ATP ratio–altering events, acti-
vated AMPK turns on ATP-generating pathways and inhibits 
ATP-consuming pathways, thereby restoring the AMP/ATP ratio 
(Williams and Brenman, 2008). AMPK was first discovered as a pro-
tein whose activity inhibited preparations of acetyl-CoA carboxy-
lase (ACC1), a regulator of cellular fatty acid synthesis (Winder 
et al., 1997). AMPK is a heterotrimeric protein with a 63-kDa cata-
lytic α subunit and two regulatory β and γ subunits (38 and 36 kDa, 
respectively), each of which is encoded by distinct genes (α1, α2; 
β1, β2; γ1, γ2, γ3; Davies et al., 1994; Mitchelhill et al., 1994; Gao 
et al., 1996; Stapleton et al., 1996; Nielsen et al., 2003), and AMPK 
is implicated in a number of signaling pathways (Hardie, 2004, 
2007; Shaw, 2009).
Upstream activation of AMPK is mediated by the tumor suppres-
sor liver kinase B1 (LKB1; Shaw et al., 2004) and Ca2+/calmodulin–
dependent kinase kinase β (Hawley et al., 2005; Hurley et al., 2005). 
Although LKB1 has clear roles in metabolism, LKB1 is also known as 
Par-4 in Caenorhabditis elegans, a key regulator of cell polarity 
(Watts et al., 2000; Chartier et al., 2011). Nonetheless, all known 
AMPK upstream kinases phosphorylate AMPKα threonine 172 
(Thr-172) in the “activation loop” of the catalytic α subunit (both α1 
and α2 isoforms), and this phosphorylation event causes >100-fold 
increase in kinase activity (Hawley et al., 1996). Conversely, dephos-
phorylation of Thr-172 by phosphatases can turn AMPK activity off 
(Sanders et al., 2007; Rubenstein et al., 2008). In general, mamma-
lian AMPK activity stimulates processes involved in ATP-producing, 
catabolic pathways (e.g., increasing the glucose transporter GLUT4 
and mitochondrial biogenesis) and inhibits ATP-consuming anabolic 
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After performing the 2D-DIGE experiments, all four adjacent 
spots of the gel corresponding to the WT or KO spots were excised 
and identified. All protein spots were confirmed to be nucleoside 
diphosphate kinase A (NDPK-A; EC 2.7.4.6), also known as Nm23 
(nonmetastatic 23). Western blotting indicated that there was no 
significant difference in NDPK protein expression levels in the total 
WT versus KO lysate fractions (Figure 1C, Load, and Supplemental 
Figure S1A). However, a difference was noted when phosphoprotein 
enrichment was performed prior to Western blot analysis for NDPK, 
which indicated more phospho-NDPK exists in WT compared with 
KO brain lysate (Figure 1C, Eluate, and Supplemental Figure S1A).
Drosophila NDPK activity is inhibited by AMPK function, 
and loss of NDPK function can compensate for loss of 
AMPKα function
Although there are multiple genes that encode for NDPK activity in 
mammals (Boissan et al., 2009), there is only a single NDPK gene in 
Drosophila with previously characterized genetic loss-of-function 
mutations available for studies. We therefore used Drosophila ge-
netics and a well-established biochemical NDPK activity assay 
(Timmons et al., 1995; Krishnan et al., 2001) to study NDPK activity 
in Drosophila. Using two genetically defined null alleles, we demon-
strated gene-dosage responsiveness for NDPK activity (Figure 2A). 
We subsequently confirmed that the decreased NDPK biochemical 
activity also roughly correlated with the NDPK protein levels de-
tected in various genetic NDPK mutant genotypes by Western blot 
(Figure 2B and Supplemental Figure S1B).
We next investigated the seemingly inverse relationship between 
NDPK and AMPK activities by reducing AMPKα function through 
the use of a transgenic RNA interference (RNAi)–based expression 
system that phenocopies genetic loss of AMPKα function and only 
allows Drosophila development to reach the late pupal/pharate 
adult stage without producing eclosing adults (Johnson et al., 2010). 
When larvae with decreased AMPKα function, through RNAi (John-
son et al., 2010; Supplemental Figure S2, A and B), were assayed for 
NDPK activity, a significant increase was observed (Figure 2C).
pathways (e.g., gluconeogenesis, lipogenesis, and protein synthe-
sis; Hardie and Hawley, 2001; Barnes et al., 2002; Holmes and 
Dohm, 2004; Hardie, 2007). The best-defined direct target of AMPK 
is the fatty acid synthesis and rate-limiting enzyme ACC, which 
AMPK phosphorylates and inhibits to subsequently lower malonyl-
CoA levels and increase fatty acid uptake into mitochondria (Merrill 
et al., 1997; Winder et al., 1997; Hardie and Hawley, 2001).
Beyond lipid synthesis, AMPK can also switch off protein synthe-
sis by using two different pathways. These pathways include activa-
tion of elongation factor-2 kinase, which causes inhibition of the 
elongation step of translation (Winder et al., 1997; Horman et al., 
2002), and inhibition of the target-of-rapamycin (TOR) pathway, 
which stimulates the initiation step of protein synthesis by the phos-
phorylation of multiple targets (Proud, 2004). TOR is directly acti-
vated by an upstream signaling pathway involving the TSC1–TSC2 
(tuberous sclerosis complex) heterodimer. AMPK directly phospho-
rylates TSC2 and thereby activates the TSC (Inoki et al., 2003). There 
is also evidence suggesting that AMPK might directly target and 
inhibit TOR (Cheng et al., 2004). More recent studies identified 
MRLC, raptor, a clock-related gene, and ULK1 as direct targets of 
AMPK (Lee et al., 2007; Gwinn et al., 2008; Lamia et al., 2009; Egan 
et al., 2011).
In this study, we searched for potential new targets of AMPK ac-
tivity. From these efforts, we identified nucleoside diphosphate ki-
nase (NDPK) as a potential downstream target of AMPKα. NDPK is 
a ubiquitous enzyme that catalyzes the transfer of the γ-phosphate 
group from a nucleoside or deoxynucleoside triphosphate (NTP or 
dNTP) to a nucleoside or deoxynucleoside diphosphate (NDP or 
dNDP, respectively) involving a high-energy phosphoenzyme inter-
mediate (Rosengard et al., 1989; Engel et al., 1995). Functionally, 
NDPK maintains pools of nucleoside and deoxynucleoside triphos-
phates for processes central to energy utilization, for example, DNA 
synthesis and translation, using diphosphate substrates (Engel et al., 
1995). In addition, the Drosophila homologue of NDPK is required 
in vivo during normal development for guided cell migration 
(Rosengard et al., 1989; Randazzo et al., 1991; Dammai et al., 2003; 
Nallamothu et al., 2008). Here we suggest mechanisms by which 
AMPK normally inhibits NDPK activity through phosphorylation of a 
highly conserved serine within NDPK.
RESULTS
Two-dimensional differential in-gel electrophoresis analyses 
identify NDPK as a phosphoprotein
The overall goal of our study was the identification of potential new 
targets of AMPK—keys for understanding energy homeostasis and 
metabolic disease that might be mediated by AMPK signaling.
We performed two-dimensional differential in-gel electrophore-
sis (2D-DIGE) using cytosolic brain lysates derived from wild-type 
(WT) and AMPKα 1/2 double-knockout (KO) mice (Williams et al., 
2011) devoid of all AMPK catalytic activity to identify proteins al-
tered in abundance or posttranslational modification between the 
WT and KO. One particular protein spot showed a potential shift in 
migration when comparing WT- and KO-derived lysates but a similar 
total abundance (Figure 1A).
Given that AMPKα functions as a kinase and the WT spot mi-
grated higher on the gel, this spot might contain a modified protein 
that was no longer phosphorylated in the KO and thus would mi-
grate differently. A second 2D-DIGE experiment was performed 
with only WT lysate. However, the WT sample was divided into two 
samples; the first sample was treated with phosphatase, and the 
second sample was untreated. A qualitatively similar result to the 
WT/KO 2D-DIGE comparison was observed (Figure 1B).
FIGURE 1: 2D-DIGE identifies NDPK as a phosphoprotein with 
reduced phosphorylation in AMPKα1/2-targeted knockout brain. 
(A) 2D-DIGE identifies overlapping/adjacent protein spots with slower 
mobility in wild-type (red) compared with AMPKα-knockout (green) 
brain. (B) Phosphatase treatment of wild-type extracts (blue) results in 
greater mobility compared with untreated samples (magenta). All four 
protein spots were identified as NDPK. (C) Although total NDPK 
protein levels are similar, immobilized metal ion affinity 
chromatography purification of phosphoproteins demonstrates more 
phospho-NDPK in wild-type brain.
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in AMPKα mutant brain suggests a potential model by which AMPK 
directly phosphorylates NDPK to inhibit NDPK function. The rela-
tionship between NDPK and AMPK was subsequently investigated 
in vitro using AMPK purified from a cell expression system (Dyck 
et al., 1996), which was subsequently added to NDPK protein. When 
these protein complexes were incubated together before perform-
ing NDPK assays, NDPK activity was significantly decreased and 
substantially further decreased upon additional AMPK activation 
(Figure 4A and Supplemental Figure S1C) with cobalt chloride (Lee 
et al., 2003; Supplemental Figure S3; CoCl2 treatment was the most 
effective AMPK activator of those tested), which demonstrates 
AMPK activity inhibits NDPK activity in vitro (Figure 4B).
After establishing that AMPK can directly phosphorylate NDPK 
in vitro, we identified potential NDPK phosphorylation sites in vivo. 
The protein spot corresponding to NDPK from WT mouse brain was 
excised for phosphopeptide mapping (Yale Mass Spectrometry 
Although these results are suggestive that AMPK might inhibit 
NDPK activity, because no prior report described the regulation of 
NDPK activity by phosphorylation, it was unclear whether loss of 
NDPK would enhance or inhibit AMPK genetic function. Initially, we 
used the transgenic RNAi-based expression system to reduce 
AMPKα function and found that introducing a single NDPK loss-of-
function mutation for either NDPK allele (Figure 2B and Supplemen-
tal Figure S1B) rescued otherwise lethal AMPKα knockdown animals 
to viability/eclosion (Table 1). In addition, heterozygous NDPK loss-
of-function alleles were able to rescue previously published (Mirouse 
et al., 2007) null AMPKα lethal loss-of-function alleles to viability as 
well, an effect otherwise only seen by dominant-negative S6 kinase, 
which is known to antagonize AMPK function (Montagne et al., 
1999). In support of these results, increased NDPK expression did 
not rescue AMPKα knockdown or loss-of-function animals but in-
stead made the transgenic animals susceptible to energetic stress 
by accelerating starvation-induced death in a defined starvation 
paradigm (Johnson et al., 2010; Figure 3).
AMPK directly inhibits NDPK activity through 
phosphorylation
The preceding results suggested that AMPK and NDPK genetically 
antagonize each other. Combination of these genetic results with 
the biochemical identification of decreased NDPK phosphorylation 
FIGURE 2: NDPK assay activity in Drosophila directly correlates with 
NDPK but inversely with AMPKα protein expression levels. 
(A) Quantification of the specific activities and (B) protein levels of the 
Drosophila NDPK alleles compared with wild-type show NDPK activity 
closely tracks NDPK protein levels (n = 5). **p < 0.001 and *p < 0.005 
vs. the wild type. (C) The RNAi-mediated reduction of the AMPKα 
level in first-instar larvae leads to an increase in NDPK activity (n = 3). 
Actin-GAL4 was the driver for the expression of the AMPKα-RNAi 
transgenic element, and the RNAi-mediated reduction of AMPKα 
protein only occurs when the GAL4 is present. ***p < 0.0005. Data 
are shown as mean ± SEM.
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FIGURE 3: NDPK transgenic overexpression in Drosophila leads to 
decreased survival under starvation conditions. Male flies (n = 30) 
were starved in empty food vials containing filter paper saturated 
with deionized H2O. Tubulin-GAL4 was the driver for overexpression 
of the NDPK transgenic element, and NDPK protein overexpression 
only occurs when the GAL4 element is present. Asterisk denotes 
statistically different values; for the 60-, 72-, 84-, and 96-h time points, 
p < 0.0072, <0.0005, <0.0001, and <0.013, respectively; n = 3. Data 
are shown as mean ± SEM.
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Transgene or 
loss-of-func-
tion mutation
 
 
AMPKα 
RNAi 
rescue (% 
expected)
AMPKα loss-
of-function 
allele 1 res-
cue (number 
rescued/total 
scored)
 
AMPKα loss-of-
function allele 
2 rescue (num-
ber rescued/
total scored)
UAS-S6k (DN) Yes (11) Yes (14/130) Yes (23/122)
UAS-TOR 
(DN)
Yes (13) No (0/68) No (0/42)
NDPK1 Yes (26) Yes (7/91) Yes (12/96)
NDPK2 Yes (41) Yes (5/101) Yes (8/71)
UAS-AMPKα Yes (100) Yes (22/65) Yes (36/75)
UAS-AMPKγ No No (0/63) No (0/94)
UAS-GFP No No (0/52) No (0/77)
TABLE 1: AMPKα RNAi and AMPKα loss-of-function rescue by NDPK.
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1989). The kinase assays revealed very similar calculated specific 
activities for the SAMS and the NDPKtide peptides, Vmax = 1.47 and 
1.29 nmol min−1 mg−1, respectively, with the SAMS peptide being 
only a slightly better—but statistically insignificant—substrate 
(Figure 6, A and B, and Supplemental Figure S7).
DISCUSSION
Elaborating targets for the cellular energy sensor AMPK is key for 
understanding the roles this molecule plays in energy homeostasis 
and metabolic disease. Through the use of proteomic techniques, 
we were able to identify proteins that are potentially regulated and/
or phosphorylated by AMPK and further prioritize these proteins for 
study based on genetic evaluation in Drosophila. On the basis of 
these criteria and studies, the protein NDPK was identified as a 
good candidate for additional study.
Phosphopeptide mapping identified a peptide (Figure 5A, un-
derlined in red) that contained a phosphorylated serine residue. Mu-
tagenesis studies performed on the two conserved serine residues 
indicated that S120 is the critical residue for NDPK regulation 
(Figure 5B), which has been a speculated but, up to this point, not 
experimentally validated mechanism for NDPK regulation 
(Venerando et al., 2011). These results correlate well with previous 
studies indicating that NDPK is phosphorylated at serine residue(s) 
Core; 73.7% coverage, including all NDPK serines and threonines; 
Supplemental Figure S4). A single peptide (Figure 5A, underlined 
red) with three candidate serines was found to contain a single 
phosphoserine. Of importance, this sequence flanked the catalytic 
NDPK histidine residue and contained three total serine residues, 
only two of which were conserved from Drosophila to human.
To identify which serine residues may be phosphorylated by 
AMPK, the two conserved serine residues were mutated singly for in 
vitro AMPK phosphorylation/NDPK activity assays. Single mutations 
of either serine (S120 or S125) to alanine in NDPK had no significant 
effect on NDPK activity. Similarly, mutating S125 to the phosphomi-
metic amino acid glutamate also had no effect on NDPK activity 
(Figure 5B). However, mutating S120 to glutamate (E) resulted in 
insoluble protein under native protein purification conditions. In ad-
dition, when solubilized under denaturing/renaturation conditions, 
the S120E mutant protein was inactive even when WT NDPK that 
underwent the same treatment maintained significant activity (Sup-
plemental Figure S5). We therefore added purified AMPK to puri-
fied NDPK protein—either WT or with the serine-to-alanine muta-
tions to measure AMPK-mediated inhibition of NDPK activity. 
Indeed, adding the AMPK complex to S125A decreased NDPK ac-
tivity; however, adding AMPK to S120A had no inhibitory effect on 
NDPK activity, suggesting that S120 is a residue that can be phos-
phorylated to inhibit NDPK activity (Figure 5B).
To determine whether AMPK could phosphorylate NDPK, in vitro 
kinase assays were performed to monitor the incorporation of 32P 
into a modified version of the NDPK phosphopeptide (the NDPK-
tide, with all serines except S120 mutated to alanine; Figure 5A and 
Supplemental Figure S6) versus the SAMS peptide, a specific, well-
established gold standard substrate for AMPK activity (Davies et al., 
FIGURE 4: Activated AMPK activity decreases NDPK activity. 
Activated AMPK decreases NDPK activity. (A) CoCl2 addition to 
HEK293 cells transiently transfected with GST-AMPKα1, HA-β1, and 
HA-γ1 increases purified activated phospho-AMPKα and (B) 
incubating purified NDPK with AMPK decreases NDPK activity. 
**p < 0.005 and *p < 0.05 vs. GST alone (n = 5).
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FIGURE 5: An identified in vivo phospho-NDPK peptide and 
identification of an AMPK-dependent NDPK phosphoserine inhibitory 
site. (A) Sequence alignment of the active-site region of NDPK (purple 
shading) and identified NDPK phosphopeptide (red underline). The 
active-site histidine and conserved serines (Ser-120 and Ser-125) are 
highlighted in green, red, and blue, respectively. (B) The specific 
activities of wild-type and each NDPK mutant with (dark-colored 
columns) and without (light-colored columns) the addition of activated 
AMPK. The decrease in activity for the S120A mutant protein was not 
statistically significant (p = 0.36, n = 3). *p < 0.05, n = 3. Data are 
shown as mean ± SEM.
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AMPK that contains the optimal AMPK-binding sequence (Gwinn 
et al., 2008). Although the NDPKtide does not contain the described 
optimal AMPK-binding sequence, several described AMPK sub-
strates also do not contain this sequence, including histone H2B, 
myosin light chain, the tumor suppressor p53, and the cyclin-depen-
dent kinase inhibitor p27 (Jones et al., 2005; Lee et al., 2007; Liang 
et al., 2007; Bjorklund et al., 2010; Bungard et al., 2010; Kim et al., 
2011). Of importance, the NDPK peptide displayed kinetic charac-
teristics similar to those of the SAMS peptide (Figure 6B), and these 
kinetic characteristics were completely abolished when S120 was 
individually mutated to an alanine (Supplementary Figure S7). Thus 
the NDPKtide sequence and serine 120 are a specific peptide re-
gion and residue targeted by AMPK for phosphorylation.
Although many studies have suggested phosphorylation may af-
fect NDPK activity, a clear genetic link to a kinase in vivo has been 
missing to this point. A previous study (Treharne et al., 2009) pro-
vided 1) biochemical evidence to indicate a direct interaction be-
tween AMPK and NDPK, although other groups have been unable 
to reproduce these results (Annesley et al., 2011), and 2) data sug-
gesting that AMPK activity decreases NDPK’s phosphotransferase 
activity through the phosphorylation of NDPK serine residues, but 
was unable to mechanistically define the interaction and indicated 
that the AMPK/NDPK interaction may still be indirect. Other studies 
investigating the AMPK/NDPK interaction have also served to con-
found this interaction—see, for example, the retractions of several 
papers that had sought to directly address this interaction biochemi-
cally (Crawford et al., 2005, 2006a, 2006b, 2007). Nevertheless, 
these retracted papers claimed that NDPK regulated and activated 
AMPK, which is not the regulatory interaction we describe here.
In our proposed model, active NDPK helps produce nucleotides 
for various anabolic pathways in the presence of inactive AMPK, that 
is, a high-energy and/or low-stress cellular state (Figure 7A). However, 
when cellular ATP falls and AMP levels rise, AMPK is activated and 
phosphorylates the critical serine 120 residue of NDPK to decrease its 
activity and, thereby, save ATP stores (Figure 7B). Thus AMPK is able 
to fulfill its primary energy gauge function and balance the formation 
of nucleotides with the conservation of ATP under energetic stress. 
Such a model might also explain why a mutation of this critical serine 
to a nonphosphorylatable glycine residue would lead to more ag-
gressive neuroblastomas (Chang et al., 1994); tumors could synthe-
size deoxynucleotides for DNA replication and use the increased 
biosynthetic products of NDPK for elevated levels of glycolysis (Green 
et al., 2011) even during energetic stress if this “off switch” was ab-
sent. This paradigm illustrates a potential direct link between tumor 
suppression and control of cellular metabolism. In addition, the acti-
vation of NDPK would also trigger an increase in the ADP/ATP ratio, 
which would further enhance AMPK activity by protecting AMPK from 
dephosphorylation. Neuroblastomas with the NDPK S120G mutation 
would then have elevated AMPK activities, as well as constitutive 
NDPK activation, which might increase glucose uptake/oxidation and 
help with tumor survival. Thus this AMPK-mediated NDPK inhibitory 
function is consistent with numerous studies suggesting that AMPK, 
as a molecule downstream of the human tumor suppressor LKB1, has 
tumor-suppressive activities (Jones et al., 2005; Shackelford and 
Shaw, 2009). Of course, it is unlikely that AMPK activity is the only 
activity capable of regulating NDPK activity; however, in brain lysates, 
it appears that AMPK activity is a major one.
MATERIALS AND METHODS
Materials
All chemicals were of an analytical grade and, unless otherwise 
noted, from Sigma-Chemical (St. Louis, MO) or Fisher Scientific (Fair 
(MacDonald et al., 1993; Almaula et al., 1995; Treharne et al., 2009). 
In fact, two prior studies, one in Escherichia coli (Almaula et al., 
1995) and a proteome-wide phospho-mapping study in Drosophila 
(Zhai et al., 2008), found this serine (S120) to be a candidate for 
phosphorylation. In addition, in vitro assays mixing protein kinase 
CK2 (CK2; formerly casein kinase 2) with NDPK demonstrated that 
serine phosphorylation of NDPK may be a mechanism to negatively 
regulate its activity (Biondi et al., 1996) and indicate that the serine 
phosphorylation of NDPK may inhibit NDPK’s phosphotransferase 
function (Treharne et al., 2009), which are in agreement with our re-
sults. Therefore, NDPK activity, which normally has a high turnover 
rate, might be partially inhibited by serine phosphorylation (Biondi 
et al., 1996). Conversely, the need for large amounts of NTPs could 
be satisfied rapidly via phosphatase-catalyzed dephosphorylation of 
NDPK, thus increasing NDPK activity (Biondi et al., 1996). However, 
until now, the mechanistic details of NDPK inhibition due to a spe-
cific phosphorylation event in vivo have been unclear.
The critical serine identified in this work, S120, is strictly con-
served in all prokaryotic and eukaryotic NDP kinases and has been 
linked to a direct involvement in the catalytic mechanism of stabiliz-
ing the NDPK catalytic site (His-118) through site-directed mutagen-
esis and crystal structure studies (Tepper et al., 1994; Giraud et al., 
2006). A serine 120-to-glycine (S120G) mutation of nm23-H1 (NDPK-
A) was even identified in several aggressive neuroblastomas (Chang 
et al., 1994). Of interest, biochemical studies indicated that this mu-
tant S120G was still active, which is comparable to our results with 
our S120 mutants (Chang et al., 1994; Freije et al., 1997).
We verified serine 120 as a residue capable of being phosphory-
lated by AMPK through the use of in vitro kinase assays and com-
parisons to the SAMS peptide, which is a specific substrate for 
FIGURE 6: In vitro AMPK kinase assays demonstrate similar kinetics 
and affinity of AMPK for NDPK and SAMS peptide. (A) Kinase assays 
were performed with purified AMPK from untransfected (untrans.) 
HEK cell lysates, kinase-dead (KD) myc-tagged AMPK, and wild-type 
(WT) myc-tagged AMPK. A synthesized NDPK peptide (containing 
only one serine, Ser-120) and the SAMS peptide were compared as 
AMPK substrates (n = 3). (B) Kinase assays were performed with 
varying amounts of the substrate peptide and WT-AMPK to measure 
the kinetics of the SAMS and NDPK peptides (n = 3).
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Carolina–Chapel Hill and in accordance with National Institutes of 
Health guidelines.
For the preparation of brain lysate, a whole mouse brain (375–
425 mg) was processed in 10 ml of ice-cold lysis buffer A (50 mM 
Tris-HCl, pH 7.5, protease [P2714; Sigma-Aldrich] and phosphatase 
[P5726; Sigma-Aldrich] inhibitor cocktails [note: for the preparation 
of the phosphatase-treated WT brain lysate for 2D-DIGE, the phos-
phatase inhibitor cocktail was omitted for 2.5 U/ml alkaline phos-
phatase (final concentration; P6774; Sigma) and the sample was in-
cubated for 1 h with the addition of 1 mM MgCl2 (37°C) before the 
high-speed centrifugation step], and benzonase nuclease) using a 
Tissuemiser homogenizer (Fisher Scientific). The lysate was centri-
fuged at 1000 × g for 20 min (4°C). The supernatant was then cen-
trifuged for a second time. The resultant clarified supernatant was 
centrifuged at 100,000 × g to produce the cytosol. The pellet was 
discarded, and the supernatant (cytosol) was directly used for West-
ern blotting and then for 2D-DIGE analyses after it was cleaned us-
ing a 2D Clean-Up Kit (GE Healthcare, Piscataway, NJ).
2D-DIGE protocols and protein identifications
The 2D-DIGE experiments were performed by the University of 
North Carolina Systems-Proteomics Center using previously de-
scribed methodologies (Osorio et al., 2007). Protein spot identifica-
tion was performed by the Yale Mass Spectrometry and Proteomics 
Resource Core (New Haven, CT) using peptide mass fingerprinting 
tandem mass spectrometry data, as previously described (Osorio 
et al., 2007; Pinaud et al., 2008).
Purification of phosphoproteins by immobilized metal 
affinity chromatography
Phosphoproteins were purified from mouse brain lysates using a 
PhosphoProtein Kit (Qiagen, Valencia, CA), as described by the 
manufacturer. The brain lysates were prepared as described; how-
ever, 0.25% 3-([3-cholamidopropyl]dimethyl-ammonio)-1-propane-
sulfonate was included in the buffer and throughout the purification 
process, as recommended by the manufacturer’s protocol.
Plasmid construction
A pET21b (Novagen, Gibbstown, NJ) construct containing the 
cDNA for wild-type NDP kinase A, inserted in the BamHI-NdeI site, 
was obtained from M.-L. Lacombe. The NDPK gene was PCR ampli-
fied from this construct using the primer pair F, 5′-AAAGGATCCG-
GCCAACTGTGAGCGTACCTTC-3′, and R, 5′-AAAGGATCCGGC-
CAACTGTGAGCGTACCTTC-3′), digested with BamHI and SalI, 
and ligated into a pET28b (Novagen) vector cut with the same re-
striction enzymes for expression as a histidine (His)-tagged protein.
Site-directed mutagenesis of NDPK was carried out using bridg-
ing PCR. The primer pairs for the construction of each NDPK variant 
are as follows: S120E (F, 5′-ATTATACATGGCGAGGATTCTGTGGA-
GAGTGC-3′; R, 5′-TCCACAGAATCCTCGCCATGTATAATGTTC-
CTG-3′), S125E (F, 5′-TTCTGTGGAGGAGGCAGAGAAGGAGAT-
CGG-3′, R, 5′-CCTTCTCTGCCTCCTCCACAGAATCACTGCC-3′), 
S120A (F, 5′-ATTATACATGGCGCTGATTCTGTGGAGAGTGC-3′, R, 
5′-TCCACAGAATCAGCGCCATGTATAATGTTCCTG-3′), and S125A 
(F, 5′-TTCTGTGGAGGCTGCAGAGAAGGAG-ATCGG-3′, R, 5′- 
CCTTCTCTGCAGCCTCCACAGAATCACTGCC-3′).
Purification of NDP kinase
Full-length His-tagged wild-type and mutant proteins were ex-
pressed in high yields using E. coli BL21-Gold (DE3) pLysS compe-
tent cells (Agilent Technologies, Palo Alto, CA) transformed with 
the appropriate construct using heat shock, as described by the 
Lawn, NJ). [γ-32P]ATP (specific activity 3000 Ci/mmol) was from 
PerkinElmer (Boston, MA). The SAMS (HMRSAMSGLHLVKRR) and 
NDPK (RNIIHGSDAVKAKRR) peptides were synthesized by Abgent 
(San Diego, CA) and the University of North Carolina Microprotein 
Sequencing and Peptide Synthesis Facility (Chapel Hill, NC), respec-
tively. The hemagglutinin (HA)-tagged human AMPKγ1 and rat 
AMPKβ1 constructs were gifts from R. Shaw. Glutathione S-trans-
ferase (GST)–tagged AMPKα1 was a gift from L. Witters. The anti-
bodies used were as follows: anti-NDPK (C-20, sc-343; Santa Cruz 
Biotechnology, Santa Cruz, CA), anti–phospho-AMPKα (40H9) and 
anti-AMPKα (23A3; Cell Signaling, Beverly, MA), and anti–α-tubulin 
(clone B-5-1-2; Sigma-Aldrich). Anti-dNDPK (reactive to protein of 
Drosophila origin, dNDPK) was a gift from T. Hsu.
Transgenic animals and brain sample/lysate preparation
Three-month-old male mice were killed to obtain brain tissue 
(kindly provided by T. Williams, University of North Carolina). The 
genotypes used were as follows: wild type, human glial fibrillary 
acidic protein-Cre (hGFAP-Cre) mice (K. McCarthy, University of 
North Carolina), and conditional AMPKα 1/2 knockout mice 
(Williams et al., 2011) to produce AMPKα1−/−α2F/F-hGFAP-Cre 
mice. The animals were handled under protocols approved by the 
Institutional Animal Care and Use Committee (Institutional Animal 
Care and Use Committee ID 09-149.0) of the University of North 
FIGURE 7: AMPK mediates inhibition of NDPK activity during 
nutrient stress. Model for AMPK-mediated NDPK inhibition. (A) Under 
nutrient-rich conditions, AMPK remains inactive, and NDPK is active 
and uses ATP as an energy source to produce nucleotides/
deoxynucleotides for several anabolic pathways. (B) During nutrient-
limiting conditions, AMPK is active (and phosphorylated at Thr-172) 
and inhibits NDPK activity through the phosphorylation of Ser-120, 
thereby conserving cellular ATP stores. Dashed lines indicate 
decreased biochemical activities.
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tion mixture containing 3–12 μg of protein in kinase buffer (50 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.0, 75 mM 
NaCl, 5 mM sodium acetate, 5 mM magnesium chloride, 1 mM di-
thiothreitol, 8% glycerol, 0.1 mM EDTA, 200 μM AMP and ATP, and 
2 μCi of [γ-32P]ATP) with or without the SAMS or NDPK peptide. Af-
ter a 30-min incubation period, the reaction mixtures were counted 
in a scintillation counter. Kinase assays with myc-tagged KD-AMPK 
and myc-tagged WT-AMPK were performed in the same manner as 
described earlier, but 0.5 μg of protein was added to the reaction 
mixture. AMPK activity is expressed as picomoles of 32P incorpora-
tion into the peptide per minute per microgram of protein.
Western blotting
Fly protein lysates for immunoblotting were prepared by collecting 
equal numbers of male and female flies (50 total) of each genotype 
in a 1.5-ml microfuge tube. One milliliter of lysis buffer A was added 
to each sample. Flies were then ground to homogeneity, incubated 
for 1 h with shaking (4°C), and centrifuged at 16,000 × g for 10 min 
(4°C). Supernatants were collected, and protein concentrations were 
determined using the Bio-Rad DC protein assay (Richmond, CA). 
Note: The preparation of brain lysate samples was described earlier.
Proteins (50 μg) were then boiled in loading buffer and subjected 
to SDS–PAGE (Invitrogen), followed by Western analyses using 
1:1000 dilutions of all primary antibodies, with the exception of 
anti–α tubulin (1:16,000). Secondary antibodies (IRDye infrared anti-
bodies; LI-COR Biosciences, Lincoln, NE) were used at a dilution of 
1:2000. Scanning, analyzing, and quantification of blots were per-
formed via the Odyssey Infrared Imaging System (LI-COR Biosci-
ences). Three or more independent experiments were performed 
for all immunoblotting data.
Fly stocks, crosses, rescue experiments, and lifespan 
measurements
Drosophila melanogaster strains obtained from the Bloomington 
Stock Center (Bloomington, IN) included the following: Act-GAL4, 
tub-GAL4, awdKRS6 (referred to as NDPK1 in this study), awdMSM95 
(NDPK2), UAS-AMPKαRNAI, the SNF1A1 and SNF1A3 mutants, UAS-
SNF1A, UAS-S6k.KQ, UAS-Tor.TED, and UAS-GFP. UAS-SNF4 and 
UAS-NDPK were gifts from D. Kretzschmar and T. Hsu, respectively. 
All flies were maintained at 25°C in yeast-cornmeal vials, and all 
crosses were also performed in cornmeal-yeasted vials.
For the AMPKα RNAi rescue experiments, males carrying a 
transgene or loss-of-function mutation on the second or third chro-
mosome were mated to virgin females carrying a GAL4 (either 
tub-GAL4 or Act-GAL4, respectively). From these crosses, male 
progeny carrying the transgene or loss-of-function mutation and 
the GAL4 were mated to virgin females carrying UAS-AMPKαRNAI. 
The progeny from this second cross were then scored for rescue, 
that is, viable adult flies in spite of AMPKα RNAi knockdown.
For the AMPKα loss-of-function rescue experiments, males carry-
ing a transgene or loss-of-function mutation on the second or third 
chromosome were mated in parallel to virgin females from both the 
SNF1A1 and SNF1A3 loss-of-function lines. The male progeny from 
both of these crosses were scored for rescue, that is, viable adult 
flies in spite of carrying the lethal loss-of-function mutation/pheno-
typically, non–bar-eyed males.
Measurements of lifespan have been widely used in Drosophila 
as a metric of stress sensitivity (Johnson et al., 2010). Thirty 3- to 
5-d-old male flies were starved in empty food vials that contained 
pieces of filter paper saturated with deionized H2O. We assessed 
the percentage survival of at least three replicate vials three times 
daily.
manufacturer, and purified using batch/gravity-flow column purifica-
tion with Talon IMAC resin (Clontech, Mountain View, CA) under 
native conditions (denaturing conditions, i.e., 4 M urea, were used 
throughout the purification process for the S120E mutant) following 
the manufacturer’s instructions.
Cell culture and AMPKα/β/γ coimmunoprecipitation
For mammalian cell expression of AMPK, the AMPK subunits were 
used as previously described (Dyck et al., 1996). HEK293 cells were 
cultured in complete DMEM (Life Technologies, Carlsbad, CA) con-
taining 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, 
GA) at 37°C in 5% CO2. For the transient expression of AMPK pro-
tein, the cells were plated 24 h before the experiments in 15-cm 
dishes and then transfected with the three plasmids using Lipo-
fectamine 2000 (1 μg DNA per 2 μl; Invitrogen, Carlsbad, CA) fol-
lowing the manufacturer’s protocols. Note: For some kinase assays, 
GST-AMPKα1 was replaced with WT or kinase-dead [KD] myc-AMPK 
(in a pCMV-myc vector; Clontech; Kazgan et al., 2010).
After 24 h, fresh medium containing CoCl2 (200 μM) was added 
to the cells for 1 h in the incubator to activate AMPK, as previously 
described (Lee et al., 2003). Cells were then harvested, lysed in 
0.5 ml of lysis buffer A plus 1.0% Triton X-100 with shaking for 1 h 
(4°C), and centrifuged at 16,000 × g for 10 min (4°C). GST- and myc-
tagged AMPK were purified from the supernatants via GST pull-
down, using glutathione Sepharose 4B (Amersham, GE Healthcare), 
and immunoprecipitation performed, using anti–c-Myc antibody 
(9E10; Developmental Studies Hybridoma Bank, University of Iowa, 
Iowa City, IA) at a 1:100 dilution for 1 mg/ml lysate and A/G agarose 
(Pierce Protein Research Products, Rockford, IL), respectively, ac-
cording to the manufacturer’s instructions and as previously de-
scribed (Kazgan et al., 2010). Washed, bead-adsorbed GST-AMPK 
was used for NDPK assays, as previously described (Dyck et al., 
1996), and both GST- and myc-tagged AMPK were used for kinase 
assays.
NDPK assays
A well-known procedure to assay NDP kinase activities was used 
(Timmons et al., 1993; Krishnan et al., 2001). In brief, 10 μl of diluted 
enzyme (lysate or purified NDPK; see further discussion) was added 
to a 990-ml reaction mixture containing 100 mM Tris-HCl, pH 7.5, 
10 mM MgCl2, 100 mM KCl, 0.4 mM NADH, 6 mM ATP, 0.7 mM 
TDP, 4 mM phosphoenolpyruvate (PEP), and 10 U of pyruvate kinase 
and lactate dehydrogenase each. The absorbance of NADH at 
340 nm was then recorded. A unit of activity is defined as the amount 
required to convert 1 μmol of NADH to NAD+ in 1 min.
For NDPK assays with flies or fly larvae, 20 adult flies or 40–50 fly 
larvae were homogenized in 50 μl of ice-cold buffer (100 mM Tris-
HCl, pH 7.5, 10 mM MgCl2, and 100 mM KCl). The lysates were 
centrifuged at 10,000 × g for 10 min (4°C). The clarified supernatant 
was then diluted 1:10 for inclusion in the described assay (0.5–2 μg 
of protein used). Purified NDPK was purchased from Sigma-Aldrich 
(N2635) and also produced as purified His-tagged versions and 
used at amounts of 10–50 and 50–200 ng, respectively, in NDPK 
assays. For the inhibition assays including AMPK, 3 μg of bead-ad-
sorbed GST-AMPK was incubated with purified NDPK or purified 
His-tagged NDPK at room temperature for 2 h before executing the 
NDPK assays.
Kinase assays
Kinase assays were performed according to previously described 
methods (Davies et al., 1989). Briefly, AMPK activity assays with GST-
AMPK were performed at room temperature (25°C) in a 25-μl reac-
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Statistical analyses
Comparisons were made using the unpaired Student’s t test with 
p < 0.05 considered significant. Values are presented as the mean ± 
the SE of the mean (SEM) and are represented as error bars. Indirect 
immunofluorescent detection of a secondary antibody (LI-COR 
Biosciences) was scanned and standardized to an internal standard 
to calculate and quantify arbitrary units using the Odyssey Infrared 
Imaging System, and a representative Western blot is shown in each 
figure.
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